JP2000515733A - ケモカインβ―１５ - Google Patents

ケモカインβ―１５

Info

Publication number
JP2000515733A
JP2000515733A JP10502860A JP50286098A JP2000515733A JP 2000515733 A JP2000515733 A JP 2000515733A JP 10502860 A JP10502860 A JP 10502860A JP 50286098 A JP50286098 A JP 50286098A JP 2000515733 A JP2000515733 A JP 2000515733A
Authority
JP
Japan
Prior art keywords
sequence
chemokine
amino acid
polypeptide
ckβ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10502860A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000515733A5 (fr
Inventor
ウェイ，イン―フェイ
クレイダー，ブレント・エル
ローゼン，クレイグ・エイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2000515733A publication Critical patent/JP2000515733A/ja
Publication of JP2000515733A5 publication Critical patent/JP2000515733A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP10502860A 1996-06-17 1996-06-17 ケモカインβ―１５ Ceased JP2000515733A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002258507A CA2258507A1 (fr) 1996-06-17 1996-06-17 Chemokine .beta.-15
PCT/US1996/010561 WO1997048807A1 (fr) 1996-06-17 1996-06-17 CHEMOKINE β-15

Publications (2)

Publication Number Publication Date
JP2000515733A true JP2000515733A (ja) 2000-11-28
JP2000515733A5 JP2000515733A5 (fr) 2004-08-19

Family

ID=25680722

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10502860A Ceased JP2000515733A (ja) 1996-06-17 1996-06-17 ケモカインβ―１５

Country Status (7)

Country Link
EP (1) EP0909320A4 (fr)
JP (1) JP2000515733A (fr)
AU (1) AU738116B2 (fr)
CA (1) CA2258507A1 (fr)
HU (1) HUP9903711A3 (fr)
IL (1) IL127551A0 (fr)
WO (1) WO1997048807A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function

Also Published As

Publication number Publication date
AU738116B2 (en) 2001-09-06
EP0909320A1 (fr) 1999-04-21
EP0909320A4 (fr) 2004-12-01
HUP9903711A2 (hu) 2000-03-28
AU6335896A (en) 1998-01-07
CA2258507A1 (fr) 1997-12-24
WO1997048807A1 (fr) 1997-12-24
IL127551A0 (en) 1999-10-28
HUP9903711A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
US6800729B2 (en) Human G-Protein chemokine receptor HDGNR10 (CCR5 receptor)
JPH10510719A (ja) ヒトｇタンパク質ケモカインレセプターｈｄｇｎｒ１０
JPH10179173A (ja) アルギナーゼｉｉ
JPH11503012A (ja) ヒトｇタンパク質結合レセプター
JP2002512521A (ja) ３２個のヒト分泌タンパク質
JPH10509328A (ja) ケラチノサイト増殖因子−２
JP2000507101A (ja) ケモカインアルファ２
US7829293B2 (en) Antibodies to chemokine β-15
JPH11507237A (ja) 単球走化性蛋白質−４
JP2000505644A (ja) ヒトｇタンパク質結合レセプター
US6537539B2 (en) Immune cell cytokine
JP2000515733A (ja) ケモカインβ―１５
US6130061A (en) Human stem cell antigen 2
WO1998007862A9 (fr) Chemokine beta-16
AU716415B2 (en) Pineal gland specific gene-1
AU771475B2 (en) Chemokine beta-15
JP2001505433A (ja) ヒトｇタンパク質レセプターｈｃｅｇｈ４５，ｐａｃａｐ様（ｇタンパク質下垂体アデニル酸シクラーゼ活性化ポリペプチド様）受容体
AU753309B2 (en) Pineal gland specific gene-1
KR20000016743A (ko) 케모카인 베타-15
MXPA98010779A (en) Quiniocina beta
WO1998007862A2 (fr) Chemokine beta-16
KR20010087423A (ko) 케모카인 베타-15
AU2004202629A1 (en) Chemokine Beta - 15
JP2001025391A (ja) ヒトｇタンパク質ケモカインレセプターｈｄｇｎｒ１０
JP2003024089A (ja) ヒト腫瘍壊死因子受容体

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050705

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20051121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060104